Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-17-044865
Filing Date
2017-02-15
Accepted
2017-02-15 12:23:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d329804dsc13ga.htm SC 13G/A 27791
  Complete submission text file 0001193125-17-044865.txt   29502
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50118 | Film No.: 17613733
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1 NORTH WACKER CHICAGO IL 60606
Business Address 1 NORTH WACKER CHICAGO IL 60606 312-525-6064
O'Connor Global Multi-Strategy Alpha Master Ltd (Filed by) CIK: 0001698095 (see all company filings)

EIN.: 980227879 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A